Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$133.02 USD
+1.02 (0.77%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $133.68 +0.66 (0.50%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/1/24 |
---|---|
Current Quarter | 1.04 |
EPS Last Quarter | 1.44 |
Last EPS Surprise | 27.43% |
ABR | 1.52 |
Earnings ESP
|
-35.58% |
---|---|
Current Year | 4.84 |
Next Year | 6.35 |
EPS (TTM) | 2.42 |
P/E (F1) | 27.29 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 515.99M | 550.88M | 2.23B | 2.56B |
# of Estimates | 11 | 10 | 11 | 11 |
High Estimate | 546.00M | 591.30M | 2.32B | 2.94B |
Low Estimate | 501.50M | 533.00M | 2.17B | 2.39B |
Year ago Sales | 420.40M | 452.70M | 1.89B | 2.23B |
Year over Year Growth Est. | 22.74% | 21.69% | 17.99% | 15.11% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.04 | 1.16 | 4.84 | 6.35 |
# of Estimates | 10 | 8 | 12 | 11 |
Most Recent Consensus | 0.67 | 1.26 | 4.80 | 6.58 |
High Estimate | 1.77 | 1.26 | 5.72 | 8.58 |
Low Estimate | 0.67 | 1.04 | 4.23 | 4.58 |
Year ago EPS | -0.79 | 0.95 | 2.47 | 4.84 |
Year over Year Growth Est. | 231.65% | 22.11% | 95.95% | 31.31% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 3 |
Up Last 60 Days | 1 | 1 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.04 | 1.16 | 4.84 | 6.35 |
7 Days Ago | 1.04 | 1.16 | 4.84 | 6.23 |
30 Days Ago | 1.05 | 1.18 | 4.88 | 6.21 |
60 Days Ago | 1.05 | 1.18 | 4.86 | 6.22 |
90 Days Ago | 1.04 | 1.15 | 4.75 | 6.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.67 | 1.26 | 4.80 | 7.27 |
Zacks Consensus Estimate | 1.04 | 1.16 | 4.84 | 6.35 |
Earnings ESP | -35.58% | 8.97% | -0.78% | 14.44% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.44 | 0.82 | 0.95 | -0.79 | NA |
Estimate | 1.13 | 0.91 | 0.77 | 0.26 | NA |
Difference | 0.31 | -0.09 | 0.18 | -1.05 | -0.16 |
Surprise | 27.43% | -9.89% | 23.38% | -403.85% | -90.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more